Literature DB >> 7589407

Comparison of twenty three nebulizer/compressor combinations for domiciliary use.

E C Smith1, J Denyer, A H Kendrick.   

Abstract

We have assessed the physical and dynamic characteristics of 23 home jet nebulizer/compressor combinations currently available in the UK and Europe. The combinations were evaluated in terms of pressure-flow characteristics, aerosol mass distribution, volume output, electrical costs, and sound level. In addition, we determined the effect of nebulizer fill volume on aerosol mass distribution and volume output. One nebulizer was used with six different compressors, and four compressors were tested with three different nebulizers. The pressure-flow relationships showed a wide variation between models, as did flow-rate at the nebulizer (range 3.0-8.0 L.min-1). The mean +/- SD volume nebulized after 10 min using an initial fill volume of 2.5 and 5.0 mL was 46 +/- 9 and 34 +/- 12%, respectively. The mass median aerodynamic diameter (MMAD) over a 5 min nebulization ranged 2.6 to 10.2 microns. Nine of the nebulizations produced an MMAD of less than 5 microns at both fill volumes. Changing nebulizer/compressor combinations affected flow rate, MMAD and volume output. Sound levels varied between models. Running costs were low, with all using less than 74 kilowatt hours of energy per year. We conclude that there is a wide variation in performance of nebulizer/compressor combinations for use with nebulized bronchodilators. Correct matching of the nebulizer/compressor is seen to be important to ensure optimum performance.(ABSTRACT TRUNCATED AT 250 WORDS)

Mesh:

Substances:

Year:  1995        PMID: 7589407     DOI: 10.1183/09031936.95.08071214

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  14 in total

1.  Selecting and using nebuliser equipment.

Authors:  A H Kendrick; E C Smith; R S Wilson
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

2.  Running a domiciliary nebuliser service.

Authors:  R S Wilson; M F Muers
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

3.  Overview of nebuliser treatment.

Authors:  M F Muers
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

4.  A radiometric study of factors affecting drug output of jet nebulizers.

Authors:  G Mittal; N Kumar; H Rawat; M K Chopra; A Bhatnagar
Journal:  Indian J Pharm Sci       Date:  2010-01       Impact factor: 0.975

5.  Nebuliser hood compared to mask in wheezy infants: aerosol therapy without tears!

Authors:  I Amirav; I Balanov; M Gorenberg; D Groshar; A S Luder
Journal:  Arch Dis Child       Date:  2003-08       Impact factor: 3.791

6.  Study of nebulization delivery of aerosolized fluorescent microspheres to the avian respiratory tract.

Authors:  Lisa A Tell; Kimberly Stephens; Stephen V Teague; Kent E Pinkerton; Otto G Raabe
Journal:  Avian Dis       Date:  2012-06       Impact factor: 1.577

Review 7.  Inhaled chemotherapy in lung cancer: future concept of nanomedicine.

Authors:  Paul Zarogoulidis; Ekaterini Chatzaki; Konstantinos Porpodis; Kalliopi Domvri; Wolfgang Hohenforst-Schmidt; Eugene P Goldberg; Nikos Karamanos; Konstantinos Zarogoulidis
Journal:  Int J Nanomedicine       Date:  2012-03-22

8.  In vitro delivery efficiencies of nebulizers for different breathing patterns.

Authors:  Hyun Mok Park; Kyung Hwa Chang; Sang-Hyub Moon; Bong Joo Park; Sun Kook Yoo; Ki Chang Nam
Journal:  Biomed Eng Online       Date:  2021-06-10       Impact factor: 2.819

9.  New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide.

Authors:  F Braido; C Lagasio; Img Piroddi; I Baiardini; Gw Canonica
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

10.  Treatment of asthma exacerbations with the human-powered nebuliser: a randomised parallel-group clinical trial.

Authors:  Christopher J Hallberg; M Therese Lysaught; René Antonio Najarro; Fausto Cea Gil; Clara Villatoro; Ana Celia Diaz de Uriarte; Lars E Olson
Journal:  NPJ Prim Care Respir Med       Date:  2014-06-26       Impact factor: 2.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.